Emcure Pharmaceuticals Q2 Results

  • BSE: 544210
  • NSE: EMCURE
  • ISIN: INE168P01015
  • Sector: -
BSE
1,390-13.35 (-0.95%)
Volume4.63 K
Updated: Fri 6 Sep, 2024 | 15:29:47
NSE
1,394.3-10.95 (-0.78%)
Volume84.38 K
Updated: Fri 6 Sep, 2024 | 15:57:58
Today: 1,385.00
1,414.90
52-Wk: 1,226.50
1,454.95

Q2 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Emcure Pharmaceuticals Q2 Results

    *All figures in crores except per share values
    Fiscal PeriodSep 23Jun 24QoQ CompSep 22YoY Comp
    Total Revenue 3,219.251,815.14N/A2,791.1915.34%
    Selling/ General/ Admin Expenses Total 918.74350.40N/A800.8914.71%
    Depreciation/ Amortization 137.4593.59N/A129.066.50%
    Other Operating Expenses Total 429.95445.32N/A395.148.81%
    Total Operating Expense 2,734.641,572.41N/A2,392.8014.29%
    Operating Income 484.61242.73N/A398.3921.64%
    Net Income Before Taxes 389.37207.41N/A296.1031.50%
    Net Income 269.56144.08N/A201.8533.55%
    Diluted Normalized EPS 14.407.95N/A10.6834.84%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts
          翻译: